Stanley Charles Erck
Net Worth

Last updated:

What is Stanley Charles Erck net worth?

The estimated net worth of Mr. Stanley Charles Erck is at least $59,775,264 as of 14 Dec 2022. He owns shares worth $618,706 as insider, has earned $41,516,558 from insider trading and has received compensation worth at least $17,640,000 in Novavax, Inc..

What is the salary of Stanley Charles Erck?

Mr. Stanley Charles Erck salary is $1,260,000 per year as Pres, Chief Executive Officer & Director in Novavax, Inc..

How old is Stanley Charles Erck?

Mr. Stanley Charles Erck is 77 years old, born in 1948.

What stocks does Stanley Charles Erck currently own?

As insider, Mr. Stanley Charles Erck owns shares in one company:

Company Title Shares Price per share Total value
Novavax, Inc. (NVAX) Pres, Chief Executive Officer & Director 65,316 $9.47 $618,706

What does Novavax, Inc. do?

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX logo
NVAX
Novavax, Inc.
$9.47

Stanley Charles Erck insider trading

Novavax, Inc.

Mr. Stanley Charles Erck has made 14 insider trades between 2011-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 226,769 units of NVAX stock on 31 Mar 2016. As of 14 Dec 2022 he still owns at least 65,316 units of NVAX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 6,966 N/A N/A
Option
Restricted Stock Units 6,966 N/A N/A
Option
Restricted Stock Units 6,546 N/A N/A
Option
Common Stock 6,546 N/A N/A
Option
Common Stock 6,967 N/A N/A
Option
Restricted Stock Units 6,967 N/A N/A
Option
Common Stock 42,829 $27.3 $1,169,232
Sale
Common Stock 42,829 $175.56 $7,518,845
Option
Stock Option (Right to Buy) 42,829 $27.3 $1,169,232
Option
Stock Option (Right to Buy) 49,000 $27.3 $1,337,700
Option
Common Stock 49,000 $27.3 $1,337,700
Sale
Common Stock 49,000 $176.63 $8,655,066
Option
Common Stock 6,546 N/A N/A
Option
Restricted Stock Units 6,546 N/A N/A
Sale
Common Stock 52,559 $216.1 $11,358,105
Option
Stock Option (Right to Buy) 25,120 N/A N/A
Sale
Common Stock 52,559 N/A N/A
Option
Common Stock 52,559 $78.8 $4,141,649
Option
Common Stock 52,559 N/A N/A
Option
Stock Option (Right to Buy) 52,620 N/A N/A
Sale
Common Stock 52,620 $212.54 $11,183,802
Sale
Common Stock 52,620 N/A N/A
Option
Stock Option (Right to Buy) 52,620 $61.07 $3,213,346
Option
Common Stock 52,620 N/A N/A
Option
Common Stock 52,620 $61.07 $3,213,346
Option
Common Stock 52,317 $32.7 $1,710,766
Sale
Common Stock 52,316 N/A N/A
Option
Stock Option (Right to buy) 52,317 N/A N/A
Option
Common Stock 52,317 N/A N/A
Option
Stock Option (Right to buy) 52,317 $32.7 $1,710,766
Sale
Common Stock 2 N/A N/A
Sale
Common Stock 12,231 N/A N/A
Sale
Common Stock 4,112 N/A N/A
Sale
Common Stock 24,995 N/A N/A
Sale
Common Stock 24,995 $112.05 $2,800,740
Option
Stock Option (Right to Buy) 25,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Option
Common Stock 6,546 N/A N/A
Option
Restricted Stock Units 6,546 N/A N/A
Option
Common Stock 6,072 N/A N/A
Option
Restricted Stock Units 6,072 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock 50,000 N/A N/A
Option
Stock Option (Right to buy) 201,991 N/A N/A
Sale
Common Stock 226,769 N/A N/A
Option
Common Stock 201,991 N/A N/A
Sale
Common Stock 198,009 N/A N/A
Option
Stock Option (Right to buy) 198,009 N/A N/A
Option
Common Stock 198,009 N/A N/A
Purchase
Common Stock 2,072 N/A N/A
Purchase
Common Stock 3,207 N/A N/A
Purchase
Common Stock 6,122 N/A N/A
Purchase
Common Stock 6,788 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 11,868 N/A N/A
Purchase
Common Stock 13,000 N/A N/A
Purchase
Common Stock 16,552 N/A N/A
Purchase
Common Stock 33,448 N/A N/A

Novavax key executives

Novavax, Inc. executives and other stock owners filed with the SEC: